TMO Licenses Integrated Genomics’ Software to Advance its Bioethanol Program
ERGO will be used to study the firm’s bioethanol conversion organism.!--h2>
TMO Renewables gained access to Integrated Genomics’ ERGO™ bioinformatics software that will aid in itsbioethanol production research.
“We believe we have developed uniquely talented high-temperature process organisms capable of producing bioethanol quickly and efficiently from a wide diversity of sustainable cellulosic feedstocks,” says Steven Martin, Ph.D., associate R&D director at TMO. “The ERGO platform will enable us to further understand and exploit our thermophilic strains to their fullest potential to deliver the next generation of green biofuels.”
TMO will utilize the ERGO genome analysis tools for gene annotation, metabolic reconstruction, enzyme data-mining, as well as comparative genomics. The tecnology integrates biological data from genomics, biochemistry, gene-expression studies, genetics, and literature. The platform combines pattern-based analyses with comparative genomics tools for gene visualization in the contexts of regulation, expression data, phylogeny, chromosomal neighborhoods, and gene fusions. ERGO contains more than 1,180 genomes at various stages of completion as well as the largest available collection of networked cellular pathways, according to the TMO.